Vor Biopharma Inc.
VOR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary
4 Item 1A. Risk Factors 30 Item 1B. Unresolved Staff Comments 81 Item 1C. Cybersecurity 81 Item 2. Properties 82 Item 3. Legal Proceedings 82 Item 4. Mine Safety Disclosures 82 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 83 Item 6. [Reserved] 83 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 84 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 95 Item 8....
Next Earnings
Q2 FY2026 — expected 2026-09-17
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | VOR | discussed_in_filing Cybersecurity | |
| topic_mention | VOR | discussed_in_filing Cybersecurity | |
| topic_mention | VOR | discussed_in_filing Cybersecurity | |
| topic_mention | VOR | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-30 | 2025-12-31 | 0001193125-26-130451 | EDGAR | 84K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042623 | EDGAR | — |
| 2024-03-20 | 2023-12-31 | 0000950170-24-034146 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009472 | EDGAR | — |
| 2022-03-14 | 2021-12-31 | 0000950170-22-003577 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015474 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280104 | EDGAR | 56K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107276 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071349 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123245 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093858 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056846 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060200 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041272 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021188 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024444 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016853 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009649 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-27 | 0001193125-26-127609 | EDGAR | 18K words |
| 2026-01-12 | 0001193125-26-009961 | EDGAR | — |
| 2026-01-02 | 0001193125-26-000905 | EDGAR | — |
| 2025-12-18 | 0001193125-25-324768 | EDGAR | — |
| 2025-12-09 | 0001193125-25-311957 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275862 | EDGAR | — |
| 2025-11-03 | 0001193125-25-261723 | EDGAR | — |
| 2025-10-28 | 0001193125-25-253636 | EDGAR | — |
| 2025-09-17 | 0001193125-25-205553 | EDGAR | — |
| 2025-09-02 | 0001193125-25-193600 | EDGAR | — |
87 total filings indexed. 59 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001817229 |
| Ticker | VOR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 49f778e0fbfc20722f7e408e96dfd9b56f5046be398140310eb4cb1cd35082b4
parent: 1f7d63d15769e33e3d3191576cf476ca251a92e2b5064a816992db90567eb4dc
content hash: c06019bf38f6599184a3e62f57235761c50c42b27e6c33a9ae5a5800a6396516
signed: 2026-04-13T04:48:07.356Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf